These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

168 related articles for article (PubMed ID: 28045361)

  • 1. [Not Available].
    Rickli H; Maeder MT
    Ther Umsch; 2016; 73(10):589-594. PubMed ID: 28045361
    [No Abstract]   [Full Text] [Related]  

  • 2. [Coagulation self management. More safety and quality of life].
    MMW Fortschr Med; 2013 Nov; 155(19):66-7. PubMed ID: 24475675
    [No Abstract]   [Full Text] [Related]  

  • 3. [Antithrombotic therapy in patients with atrial fibrillation: a comment on the European guidelines].
    Said SM; Nahrendorf W; Schmidt H; Braun-Dullaeus RC
    Dtsch Med Wochenschr; 2011 Jun; 136(25-26):1384-5. PubMed ID: 21674428
    [No Abstract]   [Full Text] [Related]  

  • 4. [Not Available].
    Santos Lopes B; Steffel J
    Ther Umsch; 2016; 73(10):551-559. PubMed ID: 28045368
    [No Abstract]   [Full Text] [Related]  

  • 5. Evaluation of SAMe-TT2R2 risk score for predicting the quality of anticoagulation control in a real-world cohort of patients with non-valvular atrial fibrillation on vitamin-K antagonists.
    Abumuaileq RR; Abu-Assi E; Raposeiras-Roubin S; López-López A; Redondo-Diéguez A; Álvarez-Iglesias D; Rodríguez-Mañero M; Peña-Gil C; González-Juanatey JR
    Europace; 2015 May; 17(5):711-7. PubMed ID: 25662984
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Procedures on patients receiving NOACs : What's possible?].
    Polzin A; Kelm M; Horn P
    Med Klin Intensivmed Notfmed; 2017 Mar; 112(2):117-124. PubMed ID: 28074294
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Discontinuing oral anticoagulation for elective surgical interventions].
    Marzan A; Ulrich Somaini S; Bächli E
    Praxis (Bern 1994); 2011 Nov; 100(23):1387-92; quiz 1393-5. PubMed ID: 22086376
    [No Abstract]   [Full Text] [Related]  

  • 8. [Evaluation of the quality of long-term anticoagulation therapy with antivitamin-K in atrial fibrillation].
    Ben Rejeb O; Brahim W; Ghali H; Ernez S; Mahdhaoui A; Jeridi G
    Ann Cardiol Angeiol (Paris); 2019 Apr; 68(2):80-86. PubMed ID: 30293798
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Long-term oral coagulation. Self monitoring prevents complication].
    MMW Fortschr Med; 2003 May; 145(19):53. PubMed ID: 12813982
    [No Abstract]   [Full Text] [Related]  

  • 10. [Oral anticoagulants. Large study finds minor risk of hemorrhage in the elderly].
    MMW Fortschr Med; 2011 Sep; 153(37):16. PubMed ID: 21950182
    [No Abstract]   [Full Text] [Related]  

  • 11. Clinical practice. Care of patients receiving long-term anticoagulant therapy.
    Schulman S
    N Engl J Med; 2003 Aug; 349(7):675-83. PubMed ID: 12917305
    [No Abstract]   [Full Text] [Related]  

  • 12. [Outpatient anticoagulation].
    Pötzsch B
    MMW Fortschr Med; 2014 May; 156(9):48-53; quiz 54-5. PubMed ID: 24908890
    [No Abstract]   [Full Text] [Related]  

  • 13. Differences in attitude, education, and knowledge about oral anticoagulation therapy among patients with atrial fibrillation in Europe: result of a self-assessment patient survey conducted by the European Heart Rhythm Association.
    Hernández Madrid A; Potpara TS; Dagres N; Chen J; Larsen TB; Estner H; Todd D; Bongiorni MG; Sciaraffia E; Proclemer A; Cheggour S; Amara W; Blomstrom-Lundqvist C
    Europace; 2016 Mar; 18(3):463-7. PubMed ID: 26899998
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Comparison of the short-term risk of bleeding and arterial thromboembolic events in nonvalvular atrial fibrillation patients newly treated with dabigatran or rivaroxaban versus vitamin K antagonists: a French nationwide propensity-matched cohort study.
    Maura G; Blotière PO; Bouillon K; Billionnet C; Ricordeau P; Alla F; Zureik M
    Circulation; 2015 Sep; 132(13):1252-60. PubMed ID: 26199338
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Bleeding while starting anticoagulation for thromboembolism prophylaxis in elderly patients with atrial fibrillation: from bad to worse.
    Wyse DG
    Circulation; 2007 May; 115(21):2684-6. PubMed ID: 17533193
    [No Abstract]   [Full Text] [Related]  

  • 16. [Monitoring of anticoagulation--management in practice].
    Schinzel H; Weilemann LS
    Dtsch Med Wochenschr; 2014 Jan; 139 Suppl 1():S27-30. PubMed ID: 24446039
    [No Abstract]   [Full Text] [Related]  

  • 17. [Vitamin K antagonists. Long-term therapy optimized by coagulation self management].
    MMW Fortschr Med; 2014 May; 156(10):78-9. PubMed ID: 24930239
    [No Abstract]   [Full Text] [Related]  

  • 18. Comparison of idraparinux with vitamin K antagonists for prevention of thromboembolism in patients with atrial fibrillation: a randomised, open-label, non-inferiority trial.
    ; Bousser MG; Bouthier J; Büller HR; Cohen AT; Crijns H; Davidson BL; Halperin J; Hankey G; Levy S; Pengo V; Prandoni P; Prins MH; Tomkowski W; Torp-Pedersen C; Wyse DG
    Lancet; 2008 Jan; 371(9609):315-21. PubMed ID: 18294998
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Maintaining therapeutic anticoagulation: the importance of keeping "within range".
    Lane DA; Lip GY
    Chest; 2007 May; 131(5):1277-9. PubMed ID: 17494777
    [No Abstract]   [Full Text] [Related]  

  • 20. [Anticoagulation in atrial fibrillation. Strategies in special situations].
    Volkmann H; Walter M; Walter C; Vetter S
    Clin Res Cardiol Suppl; 2011 May; 6():58-65. PubMed ID: 22528179
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.